Pfizer Inc. buy Guggenheim
Start price
18.03.25
/
50%
€24.09
Target price
18.03.26
-
Performance (%)
-1.62%
End price
19.03.26
€23.70
Summary
This prediction ended on 19.03.26 with a price of €23.70. With a performance of -1.62%, the BUY prediction by Guggenheim finished with a loss. Guggenheim has a follow-up prediction for Pfizer Inc. where he still thinks Pfizer Inc. is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pfizer Inc. | -0.193% | -0.193% | -3.463% |
| iShares Core DAX® | -4.932% | -11.977% | -3.667% |
| iShares Nasdaq 100 | -2.634% | -2.218% | 14.638% |
| iShares Nikkei 225® | -4.733% | -10.900% | 19.738% |
| iShares S&P 500 | -2.544% | -3.540% | 9.339% |
Comments by Guggenheim for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) had its "buy" rating re-affirmed by analysts at Guggenheim.
Ratings data for PFE provided by MarketBeat
In the thread Trading Pfizer Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten